Sanofi's sleep­ing sick­ness drug wins FDA OK and a lu­cra­tive pri­or­i­ty re­view vouch­er too

The FDA on Tues­day ap­proved the first oral treat­ment for sleep­ing sick­ness (hu­man African try­panoso­mi­a­sis) from Sanofi and the Drugs for Ne­glect­ed Dis­eases ini­tia­tive, and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER